BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10642839)

  • 1. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.
    Norlund MA; Lee JM; Zainelli GM; Muma NA
    Brain Res; 1999 Dec; 851(1-2):154-63. PubMed ID: 10642839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
    Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
    Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy.
    Zemaitaitis MO; Lee JM; Troncoso JC; Muma NA
    J Neuropathol Exp Neurol; 2000 Nov; 59(11):983-9. PubMed ID: 11089576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles.
    Nemes Z; Devreese B; Steinert PM; Van Beeumen J; Fésüs L
    FASEB J; 2004 Jul; 18(10):1135-7. PubMed ID: 15132984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
    Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
    J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.
    Johnson TS; Griffin M; Thomas GL; Skill J; Cox A; Yang B; Nicholas B; Birckbichler PJ; Muchaneta-Kubara C; Meguid El Nahas A
    J Clin Invest; 1997 Jun; 99(12):2950-60. PubMed ID: 9185519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
    Wilhelmus MM; de Jager M; Bakker EN; Drukarch B
    J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau.
    Dudek SM; Johnson GV
    J Neurochem; 1993 Sep; 61(3):1159-62. PubMed ID: 8103081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase cross-links in intranuclear inclusions in Huntington disease.
    Zainelli GM; Ross CA; Troncoso JC; Muma NA
    J Neuropathol Exp Neurol; 2003 Jan; 62(1):14-24. PubMed ID: 12528814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains.
    Zhang J; Wang S; Huang W; Bennett DA; Dickson DW; Wang D; Wang R
    Mol Neurobiol; 2016 Oct; 53(8):5066-78. PubMed ID: 26386840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures.
    Appelt DM; Balin BJ
    Brain Res; 1997 Jan; 745(1-2):21-31. PubMed ID: 9037390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dityrosine Cross-links are Present in Alzheimer's Disease-derived Tau Oligomers and Paired Helical Filaments (PHF) which Promotes the Stability of the PHF-core Tau (297-391) In Vitro.
    Maina MB; Al-Hilaly YK; Oakley S; Burra G; Khanom T; Biasetti L; Mengham K; Marshall K; Harrington CR; Wischik CM; Serpell LC
    J Mol Biol; 2022 Oct; 434(19):167785. PubMed ID: 35961386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunochemical study on tau glycation in paired helical filaments.
    Ko LW; Ko EC; Nacharaju P; Liu WK; Chang E; Kenessey A; Yen SH
    Brain Res; 1999 Jun; 830(2):301-13. PubMed ID: 10366687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of transglutaminase-catalyzed isopeptide bonds in paired helical filaments and neurofibrillary tangles from Alzheimer's disease.
    Balin BJ; Loewy AG; Appelt DM
    Methods Enzymol; 1999; 309():172-86. PubMed ID: 10507024
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients.
    Harrington CR; Wischik CM; McArthur FK; Taylor GA; Edwardson JA; Candy JM
    Lancet; 1994 Apr; 343(8904):993-7. PubMed ID: 7909090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.